Literature DB >> 1621412

Clinical and bacteriological studies of El Tor cholera after ingestion of known inocula in Thai volunteers.

P Suntharasamai1, S Migasena, U Vongsthongsri, W Supanaranond, P Pitisuttitham, L Supeeranan, A Chantra, S Naksrisook.   

Abstract

Twenty-six healthy adult Thai volunteers were recruited for clinical and bacteriological studies of cholera induced by oral inoculation with Vibrio cholerae El Tor Inaba strain N16961. Vibrio dosages of 0.3 x 10(4), 1.6 x 10(5) and 1.9 x 10(6) c.f.u. were given to three groups of five volunteers, and 2.0 x 10(7) c.f.u. to 11 volunteers. Diarrhoeal attack rates correlated positively with the size of the inocula (p less than 0.01). It was estimated that a diarrhoeal attack rate of 90% (ED90) would be achievable by inoculation of 1.3 x 10(7) c.f.u. of the organisms. There were no significant differences between the groups in the latent period to positive stool culture, maximum vibrio count per gram of stool and duration of stool positivity. The ED90 of V. cholerae obtained may be used as a challenge dose in subsequent studies on protective efficacy of cholera vaccines in Thai adult volunteers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1621412     DOI: 10.1016/0264-410x(92)90347-m

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Authors:  Marcela F Pasetti; Myron M Levine
Journal:  Clin Vaccine Immunol       Date:  2012-09-19

2.  Cholera and severe toxigenic diarrhoeas.

Authors:  D R Nalin
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

Review 3.  Modeling cholera outbreaks.

Authors:  Dennis L Chao; Ira M Longini; J Glenn Morris
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  Ethical challenges posed by human infection challenge studies in endemic settings.

Authors:  Michael J Selgelid; Euzebiusz Jamrozik
Journal:  Indian J Med Ethics       Date:  2018-09-18

5.  The utility of human challenge studies in vaccine development: lessons learned from cholera.

Authors:  Debbie-Ann T Shirley; Monica A McArthur
Journal:  Vaccine (Auckl)       Date:  2011-10

Review 6.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

Review 7.  Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy.

Authors:  Euzebiusz Jamrozik; Michael J Selgelid
Journal:  J Med Ethics       Date:  2020-05-07       Impact factor: 2.903

8.  Conducting human challenge studies in LMICs: A survey of researchers and ethics committee members in Thailand.

Authors:  Jaranit Kaewkungwal; Pornpimon Adams; Jetsumon Sattabongkot; Reidar K Lie; David Wendler
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

9.  Aerobic Metabolism in Vibrio cholerae Is Required for Population Expansion during Infection.

Authors:  Andrew J Van Alst; Victor J DiRita
Journal:  mBio       Date:  2020-09-01       Impact factor: 7.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.